2012 Midyear Clinical Meeting
Click here to go to the previous page
Hepatitis C in 2012: The Clinical Pharmacist's Role in Successful Treatment
Track:
Education Sessions (CE)
Program Code: 205-L01
Date: Tuesday, December 4, 2012
Time: 8:15 AM to 9:15 AM EST
Location:
South Seas J, Level 3, South Convention Center
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Jacqueline Olin,
PharmD, MS, Associate Professor of Pharmacy,
Wingate University School of Pharmacy
|
Dr. Olin received her Doctor of Pharmacy degree from Rutgers, the State University of New Jersey. She completed a pharmacy practice residency at the Robert Wood Johnson University Hospital in New Brunswick, New Jersey. Dr. Olin is a board certified pharmacotherapy specialist, clinical pharmacist practitioner, and a certified diabetes educator. She is currently an Associate Professor at Wingate University School of Pharmacy. Dr. Olin's interests are varied within the realm of adult internal medicine.
|
Linda Spooner,
PharmD, BCPS, Associate Professor of Pharmacy Practice,
Massachusetts College of Pharmacy and Health Sciences
|
Dr. Spooner received her Bachelor of Science in Pharmacy from the University of Connecticut and her Doctor of Pharmacy degree from the University of Oklahoma. She completed a specialty residency in internal medicine pharmacy practice at the University of Texas at Austin/Brackenridge Hospital. Dr. Spooner is a board certified pharmacotherapy specialist, with added qualifications in infectious diseases. She maintains a clinical practice in infectious diseases and internal medicine at Saint Vincent Hospital in Worcester. She also participates in weekly HIV and hepatitis C clinics.
Dr. Spooners interests include infectious diseases, with emphasis in the pharmacotherapy of HIV infection and hepatitis C infection. In addition to publishing textbook chapters and articles reviewing antiretroviral drug therapy and therapy for hepatitis C infection, Dr. Spooner has participated in numerous research projects within the realm of infectious diseases. She also provides continuing education presentations for postgraduate pharmacy residents and fellows in the area of preceptor skill development.
Dr. Spooner is a member of the American College of Clinical Pharmacy and the American Society of Health-System Pharmacists. She also serves on the Editorial Advisory Board for the Journal of Managed Care Pharmacy.
|
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
Linda Spooner,
PharmD, BCPS, Associate Professor of Pharmacy Practice,
Massachusetts College of Pharmacy and Health Sciences
|
Dr. Spooner received her Bachelor of Science in Pharmacy from the University of Connecticut and her Doctor of Pharmacy degree from the University of Oklahoma. She completed a specialty residency in internal medicine pharmacy practice at the University of Texas at Austin/Brackenridge Hospital. Dr. Spooner is a board certified pharmacotherapy specialist, with added qualifications in infectious diseases. She maintains a clinical practice in infectious diseases and internal medicine at Saint Vincent Hospital in Worcester. She also participates in weekly HIV and hepatitis C clinics.
Dr. Spooners interests include infectious diseases, with emphasis in the pharmacotherapy of HIV infection and hepatitis C infection. In addition to publishing textbook chapters and articles reviewing antiretroviral drug therapy and therapy for hepatitis C infection, Dr. Spooner has participated in numerous research projects within the realm of infectious diseases. She also provides continuing education presentations for postgraduate pharmacy residents and fellows in the area of preceptor skill development.
Dr. Spooner is a member of the American College of Clinical Pharmacy and the American Society of Health-System Pharmacists. She also serves on the Editorial Advisory Board for the Journal of Managed Care Pharmacy.
|
Description
Overview of Current HCV Management: Administration, Adverse Effects, and Drug Interactions, Linda M. Spooner, PharmD, BCPS
Incorporating HCV Management into Your Pharmacy Practice, Jacqueline L. Olin, PharmD, MS
- Evaluate treatment options for managing Hepatitis C Virus (HCV) infection in 2012.
- Identify key considerations in counseling patients with HCV infection, including adverse effect management, adherence concerns, and avoidance of drug interactions.
- Plan how to incorporate HCV management into pharmacy practice.
